Company news

Labcorp Holdings Inc. (NYSE:LH) news

Labcorp Holdings Inc. news releases on 6ix. Latest, Oct 28, 2025: Labcorp Announces 2025 Third Quarter Results

View Labcorp Holdings Inc. →

Press releases — page 2

Labcorp Announces 2025 Third Quarter Results

October 28, 2025

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

October 23, 2025

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

October 20, 2025

Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities

September 30, 2025

Labcorp to Announce Third Quarter Financial Results on October 28, 2025

September 25, 2025

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

September 15, 2025

Vesey Street Capital Partners Adds Three Seasoned Healthcare Industry Leaders to Strategic Advisory Board

September 8, 2025

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs

September 3, 2025

Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 27, 2025

Harnessing the Power of Laboratory Data to Optimize Trial Design, Site Identification and Patient Recruitment, Upcoming Webinar Hosted by Xtalks

August 21, 2025

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

August 18, 2025

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

July 30, 2025

Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU

July 29, 2025

Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry

July 28, 2025

Labcorp Announces 2025 Second Quarter Results

July 24, 2025

Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp

July 22, 2025

Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer

July 8, 2025

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

June 27, 2025

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

June 26, 2025

Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care

June 18, 2025

PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership

June 18, 2025

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

June 12, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research

May 30, 2025

Labcorp to Webcast Its Annual Meeting of Shareholders May 15

May 8, 2025

Labcorp Announces 2025 First Quarter Results

April 29, 2025

Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions

April 23, 2025

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease

April 2, 2025

Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide

April 1, 2025

Labcorp to Announce First Quarter Financial Results on April 29, 2025

March 31, 2025

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

March 11, 2025

Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

February 24, 2025

← Newer